Skip to content
PIL Logo

Sustanon 250, 250mg/ml solution for injection

Last Updated on eMC 23-Dec-2016 View document  | Aspen Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23-Dec-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 31-Mar-2015 and displayed until 23-Dec-2016

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 3 - dose and frequency
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store
  • Change to section 6 - date of revision

Updated on 16-Dec-2014 and displayed until 31-Mar-2015

Reasons for adding or updating:

  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 01-May-2014 and displayed until 16-Dec-2014

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Aspen

Company image
Address

3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland

Medical Information Direct Line

0800 0087 392

Telephone

+ 44 1748 828 391

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

testosterone decanoate , testosterone isocaproate, testosterone phenylpropionate, testosterone propionate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue